Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran
11/02/2026 11:01
Feb 11 (Reuters) - Bioxytran Inc BIXT.PK: BIOXYTRAN REPORTS POSITIVE PHASE 2 RESULTS DEMONSTRATING RAPID VIRAL CLEARANCE WITH PROLECTIN-MBIOXYTRAN BIOXYTRAN INC - NO VIRAL REBOUNDS OBSERVED DURING 14-DAY POST-TREATMENT PERIOD Source text: ID:nGNX8BRf9b Further company coverage: BIXT.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioxytran
See all newsUS officials pressed China on rare earths, farm goods commitments, Bessent says (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran